In this column, Ayush Dubey, MBA candidate at Yale School of Management, talks about his his semester abroad at London ...

Common warts affects approximately 22 million patients in the United States alone, and there are no FDA approved prescription therapies for ...

Chinese semiconductor designer Montage Technology plans a second listing in Hong Kong via a $800 million to $1 billion share ...

Common warts affects approximately 22 million patients in the United States alone, and there are no FDA approved prescription therapies for what is believed to be a multibillion-dollar market opportun ...

Kharabi led development of CD19 CAR-T therapy TECARTUS®; brings extensive cell and gene therapy expertise to guide 3T’s bispecific T-cell engager programs into the clinicKnudsen oversees more than 100 ...

Golub Capital delivered another year of "good boring," consistent results for its stakeholders in 2025, aided by its commitment to specialization.

ORION CORPORATION PRESS RELEASE 8 JANUARY 2026 at 12.00 EET Orion Pharma announces the initiation of TEADES Phase 2 trial of ...

Larry Pitcher is the CEO of Kincell Bio. He brings over 20 years of leadership experience in biopharmaceutical manufacturing, ...

Favorable safety, tolerability, pharmacokinetic and pharmacodynamic profiles validate and significantly de-risk the programSupports the ...

British University Vietnam (BUV) has been cited by QS (Quacquarelli Symonds) as a case study illustrating how a multi-level ...